Dan Sharp, Director, OTC, UT Austin

advertisement

The University of Texas at Austin

Office of Technology Commercialization

Creating New Approaches to Innovation

P R E S E N T E D B Y D A N S H A R P, D I R E C T O R

T O S B I R / S T T R S U M M I T & C O N F E R E N C E

J A N U A R Y 1 9 , 2 0 1 2

The University of Texas at Austin

51,000+ students; 3,344 faculty

$642MM in annual research funding

$25.6MM/year revenue from licensing and royalty

Over 1,000 patents filed in last 5 years

 UT System ranked No. 3 by Patent Scorecard™

$60MM industry-sponsored research from leading companies; e.g., Abbott, Chevron, Merck, ExxonMobil, Intel, Cisco,

Samsung, BASF, Boeing, Lockheed Martin, Pfizer

Office of Technology Commercialization:

Who we are

The Office of Technology Commercialization is responsible for the efficient transfer of university discoveries to the marketplace for the benefit of society. To support the university's research mission, OTC:

Evaluates, protects, markets, and licenses the university’s inventions and software

Promotes collaboration with industry, investors, and others within the tech commercialization ecosystem

Informs the university's faculty on patent protection and commercialization processes

OTC reports to the Office of the Vice President for Research

Office of Technology Commercialization:

What we do

Initial technology disclosure evaluation and due diligence

Patent strategy development

Patent application and prosecution

Business development

 Interaction and negotiation with potential licensees

Marketing and faculty outreach

Tech transfer: Licensing technology to third parties

Leveraging UT technologies into funded, emerging growth companies

License and patent enforcement

Office of Technology Commercialization:

Services we provide to you

Legal introductions (corporate formation and funding transactions)

Funding introductions (angels, VCs, corporate/strategic partners)

Management introductions

 Seasoned entrepreneurs with solid track records and domain expertise to develop business model and strategy

 Traditional “business development”

 Leverage the collective OTC network and that of UT Austin to accelerate market validation, feedback, and company/technology development

Proper handoff to the appropriate service providers/business partner

Office of Technology Commercialization:

Where we play

Company

 Formation

Office of

Technology

Commercialization

Austin

Technology

Incubator Angels Venture Capital

Time 

Office of Technology Commercialization:

How we educate faculty

Colloquium on Commercialization Series

October 14, 2011 – “Startup to IPO: Building for Success”

November 9, 2011 – “Licensing and Corporate Partnering”

December 6, 2011 – “Inventor of the Year Ceremony and

Reception”

February 22, 2012 – “What You Need to Know About Patents

For faculty, postdocs/grad students, and invited guests only

To learn more, visit: www.otc.utexas.edu/Events/Colloquium/

Send inquiries to webmarketing@otc.utexas.edu

Increase Quality, Not Quantity, of

Disclosures and New Patent Filings

An iterative process with professors and students that can lead to stronger, more prominent, and more valuable patent portfolios

Getting to “No” faster, in order to spend more quality time with potential winners

Engaging high-quality patent attorneys earlier in the process to discuss, evaluate, and recommend optimum patent strategies

Results

 Disclosures/patent filings

 Legal fees and administrative costs

 Revenue from higher-quality tech transfer

New US Patents Filed, FY 2010-11

COCKRELL SCHOOL OF ENGINEERING . . . . . . . . . . . . . . . . . . . .

Biomedical Engineering

Chemical Engineering

Civil, Architectural and Environmental Engineering

Electrical and Computer Engineering

Mechanical Engineering

Petroleum and Geosystems Engineering

COLLEGE OF NATURAL SCIENCES . . . . . . . . . . . . . . . . . . . . . . . .

Chemistry and Biochemistry

Computer Science

Institute for Cellular and Molecular Biology

Physics

School of Biological Sciences

VICE PRESIDENT FOR RESEARCH . . . . . . . . . . . . . . . . . . . . . . . .

Applied Research Laboratories (ARL)

Center for Electromechanics

Institute for Advanced Technology

SCHOOL OF PHARMACY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Pharmaceutics

Pharmacy Practice

COLLEGE OF LIBERAL ARTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

Psychology

0

11

19

4

11

12

8

14

2

1

1

10

1

2

3

4

2

2

3

4 6 8 10 12 14 16 18 20

N.B.: Total equals more than 100% of patent count because of multiple inventors in different departments.

Impact of Focus on Quality

Higher quality patent filings

200

180

160

140

120

100

80

60

40

20

0

182

155

Disclosures

133

69

New patent filings

FY09-10

FY10-11

FY 10/11 – Licensing Revenue: $25,641,730

$68 693

$2 114 440

$11 318 147

©2011, Office of Technology Commercialization

$12 140 451

Inventors (44.1%)

Departments (8.2%)

Third Parties (0.3%)

Retained by UT Austin (47.3%)

11

The Austin and Texas Technology Ecosystem

Research and

Innovation

Technology

Development

Government and

Industry Engagement and Funding

Licensing and

New Company

Formation

Faculty and

Students

Venture

Capital

Success

Stories

Download